J. Bradley Layton

Has grant

Health Solutions

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

COMPARATIVE EFFECTIVENESS AND SAFETY OF INFLUENZA IMMUNIZATION STRATEGIES IN THE DIALYSIS POPULATION

Open Date: 2018-05-01

Close Date:

Grant: Close

Effectiveness and Safety of Tdap Immunization in Pregnancy

Open Date: 2015-04-08

Close Date: 2018-03-31

Grant: Close

Patterns of use, comparative effectiveness, and safety of rotavirus vaccines

Open Date: 2013-12-01

Close Date: 2016-11-30

Grant: Close

Heat Waves, Medication Use, and Adverse Health Outcomes Among Older Adults

Open Date: 2013-09-30

Close Date: 2017-06-30

Grant: Close

A retrospective cohort study of the safety of testosterone therapy in older men

Open Date: 2012-09-01

Close Date: 2015-08-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Jetty Overbeek

Head of R&D

NETHERLANDS

View details

Lisa McQuay

Health Solutions

UNITED STATES

View details

Dorey Glenn

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Christian Christiansen

Aarhus University

DENMARK

View details

Mary Anthony

Health Solutions

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

J. Bradley Layton

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study

Plain language summary of mortality rates of patients with Parkinson’s disease psychosis who were treated either with pimavanserin or with different second-generation (atypical) antipsychotics

Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson’s Disease Psychosis: An Update

Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the United States: A Cohort Study from the FOUNTAIN platform

Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States

A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

FOUNTAIN: a modular research platform for integrated real-world evidence generation

Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study

Influenza Vaccine Administration and Effectiveness Among Children and Adults With Glomerular Disease

Collaborators (5)

Jetty Overbeek

Lisa McQuay

Dorey Glenn

Christian Christiansen

Mary Anthony

Make your next move.